Abstract:Natural killer (NK) cell can inhibit tumor initiation and regulates metastatic dissemination, acting as key mediators of the innate immune response. Intrinsic factors modulating NK cells infiltration and its anticancer activity remain poorly characterized. We investigated the roles of dysregulation of micro(mi) RNAs and NK cells in progression of hepatocellular carcinoma (HCC). Methods: Small RNA sequencing were used to detect the miRNA profiles of tumor tissues from HCC patients with (n=14) or without (n=13) pulmonary metastasis and HCC cell lines with different pulmonary metastatic potentials. Chemokine expression profiling and bioinformatics were used to detect the downstream target of candidate target. In gain-and loss-of-function assays were used to investigate the role of miRNA in HCC progression. Different subsets of NK cells were isolated and used for chemotaxis and functional assays in vivo and in vitro. In situ hybridization and immunohistochemical analyses were performed to detect the expression of miRNA in tumor tissues from 242 HCC patients undergoing curative resection from 2010. Results: Three miRNAs (miR-137, miR-149-5p, and miR-561-5p) were identified to be associated with pulmonary metastasis in patients with HCC. miR-561-5p was most highly overexpressed in metastatic HCC tissues and high-metastatic-potential HCC cell lines. In gain-and loss-of-function assays in a murine model, miR-561-5p promoted tumor growth and spread to the lungs. Yet, miR-561-5p did not appear to affect cellular proliferation and migration in vitro. Bioinformatics and chemokine expression profiling identified chemokine (C-X3-C motif) ligand 1 (CX(3)CL1) as a potential target of miR-561-5p. Furthermore, miR-561-5p promoted tumorigenesis and metastasis via CX(3)CL1-dependent regulation of CX(3)CR1(+) NK cell infiltration and function. CX(3)CR1(+) NK cells demonstrated stronger in vivo anti-metastatic activity relative to CX(3)CR1(-) NK cells. CX(3)CL1 stimulated chemotactic migration and cytotoxicity in CX(3)CR1(+) NK cells via STAT3 signaling. Blockade of CX(3)CL1, CX(3)CR1, or of pSTAT3 signaling pathways attenuated the antitumor responses. Clinical samples exhibited a negative correlation between miR-561-5p expression and levels of CX(3)CL1 and CX(3)CR1(+) NK cells. High miR-561-5p abundance, low CX(3)CL1 levels, and low numbers of CX(3)CR1(+) NK cells were associated with adverse prognosis. Conclusion: We delineated a miR-561-5p/CX(3)CL1/NK cell axis that drives HCC metastasis and demonstrated that CX(3)CR1(+) NK cells serve as potent antitumor therapeutic effectors.

Role of CD61+ low-density neutrophils in promoting hepatocellular carcinoma metastasis through CCDC25 upregulation

Zinc Finger Protein 296 Promotes Hepatocellular Carcinoma Progression Via Intervening Interaction Between Macrophages and B Cells.

The Crosstalk Between Cancer Cells and Neutrophils Enhances Hepatocellular Carcinoma Metastasis via Neutrophil Extracellular Traps-Associated Cathepsin G Component: A Potential Therapeutic Target

Tumor-derived HMGB1 induces CD62Ldim neutrophil polarization and promotes lung metastasis in triple-negative breast cancer

Overexpression of CXCL5 Mediates Neutrophil Infiltration and Indicates Poor Prognosis for Hepatocellular Carcinoma.

Tumor-Associated Neutrophils: an Emerging Player in the Immune Microenvironment of Hepatocellular Carcinoma

Increased Neutrophil Extracellular Traps Promote Metastasis Potential of Hepatocellular Carcinoma Via Provoking Tumorous Inflammatory Response.

Neutrophils: Driving inflammation during the development of hepatocellular carcinoma

Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma

Group-2 Innate Lymphoid Cells Promote HCC Progression Through CXCL2-Neutrophil-Induced Immunosuppression.

Characterizing ligand-receptor interactions and unveiling the pro-tumorigenic role of CCL16-CCR1 axis in the microenvironment of hepatocellular carcinoma

Single‚Äźcell profiling reveals the metastasis‚Äźassociated immune signature of hepatocellular carcinoma

Ccr6(+) B Lymphocytes Responding to Tumor Cell-Derived Ccl20 Support Hepatocellular Carcinoma Progression Via Enhancing Angiogenesis

Single‐cell Profiling Reveals the Metastasis‐associated Immune Signature of Hepatocellular Carcinoma

CD44 Potentiates Hepatocellular Carcinoma Migration and Extrahepatic Metastases Via the AKT/ERK Signaling CXCR4 Axis.

Group‐2 Innate Lymphoid Cells Promote Hepatocellular Carcinoma Progression via CXCL2‐Neutrophil Induced Immunosuppression

NLRC3 High Expression Represents a Novel Predictor for Positive Overall Survival Correlated with CCL5 and CXCL9 in HCC Patients

The HN1/HMGB1 Axis Promotes the Proliferation and Metastasis of Hepatocellular Carcinoma and Attenuates the Chemosensitivity to Oxaliplatin

Expression and clinical significance of NLRC5 in hepatocellular carcinoma

HN1L-mediated Transcriptional Axis AP-2γ/METTL13/TCF3-ZEB1 Drives Tumor Growth and Metastasis in Hepatocellular Carcinoma.

The miR-561-5p/CX 3 CL1 Signaling Axis Regulates Pulmonary Metastasis in Hepatocellular Carcinoma Involving CX 3 CR1 + Natural Killer Cells Infiltration.